A randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor.

Authors

null

Paul Swiecicki

University of Michigan Rogel Cancer Center, Ann Arbor, MI

Paul Swiecicki , Emily Bellile , Keith Casper , Kelly M Malloy , Robbi Kupfer , Matthew E Spector , Andrew Shuman , Steven Bennett Chinn , Chaz Stucken , Ashok Srinivasan , Dawn Owen , Aleksandar Filip Dragovic , Michelle Mierzwa , Shruti Jolly , Carol Rossier Bradford , Avraham Eisbruch , Thomas E. Carey , Mark E Prince , Gregory T. Wolf , Francis P. Worden

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT01633541

Citation

J Clin Oncol 37, 2019 (suppl; abstr 6066)

DOI

10.1200/JCO.2019.37.15_suppl.6066

Abstract #

6066

Poster Bd #

55

Abstract Disclosures